Table 2.
Clinico-pathologic characteristics
| Normal Weight (n = 59) |
Overweight (n = 44) |
Obese (n = 58) |
p-value | |
|---|---|---|---|---|
| Cancer Diagnosis | 0.359 | |||
| Cervix (n=86) | 27 (45.8%) | 29 (65.9%) | 30 (51.7%) | |
| Vulva (n=21) | 8 (13.6%) | 5 (11.4%) | 8 (13.8%) | |
| Vagina (n=38) | 19 (32.2%) | 7 (15.9%) | 12 (20.7%) | |
| Uterus (n=15) | 4 (6.8%) | 3 (6.8%) | 8 (13.8%) | |
| Other (n=1) | 1 (1.7%) | 0 (0%) | 0 (0%) | |
| Histology | 0.123 | |||
| Squamous (n=98) | 31 (52.5%) | 32 (72.7%) | 35 (60.3%) | |
| Adenocarcinoma (n=36) | 15 (25.4%) | 6 (13.6%) | 15 (25.9%) | |
| Adenosquamous (n=6) | 3 (5.1%) | 3 (6.8%) | 0 (0%) | |
| Melanoma (n=8) | 5 (8.5%) | 0 (0%) | 3 (5.2%) | |
| Clear Cell (n=1) | 0 (0%) | 1 (2.3%) | 0 (0%) | |
| Other (n=10) | 4 (6.8%) | 2 (4.5%) | 4 (6.9%) | |
| Missing | 1 | 0 | 1 | |
| Indication for Surgery | 0.796 | |||
| Primary (n=17) | 8 (13.6%) | 4 (9.1%) | 5 (8.6%) | |
| Recurrent (n=124) | 44 (74.6%) | 36 (81.8%) | 44 (75.9%) | |
| Persistent (n=20) | 7 (11.9%) | 4 (9.1%) | 9 (15.5%) | |
| Prior Treatment | 0.346 | |||
| Chemoradiation | 10 (17.2%) | 10 (22.7%) | 14 (24.1%) | |
| Radiation alone | 16 (27.6%) | 12 (27.3%) | 17 (29.3%) | |
| Surgery + Radiation | 12 (20.7%) | 8 (18.2%) | 4 (6.9%) | |
| Surgery + Chemoradiation | 2 (3.4%) | 4 (9.1%) | 5 (8.6%) | |
| Surgery + Chemotherapy | 1 (1.7%) | 1 (2.3%) | 2 (3.4%) | |
| Surgery alone (non-exent) | 8 (13.8%) | 5 (11.4%) | 11 (19%) | |
| Upfront Exenteration | 9 (15.5%) | 2 (4.5%) | 5 (8.6%) | |
| Preop Radiation with Planned Exent | 0 (0%) | 2 (4.5%) | 0 (0%) | |
| Missing | 1 | 0 | 0 | |